Key result
Elevated ESR linked to ~46% greater risk of developing heart failure over 30 years.
Why the study?
Inflammation is implicated in heart failure pathophysiology and inflammatory markers predict future HF, but whether the inexpensive systemic inflammatory marker ESR predicts subsequent HF was unknown.
Does elevated erythrocyte sedimentation rate predict the development of heart failure in middle-aged men free from baseline cardiovascular disease?
Cohort (n=2,314)
Does elevated erythrocyte sedimentation rate predict the development of heart failure in middle-aged men free from baseline cardiovascular disease?
Hazard Ratio: 1.46 (95% CI 1.04–2.06)
Elevated erythrocyte sedimentation rate is an independent predictor of incident heart failure over a 30-year follow-up in middle-aged men, suggesting inflammation plays an early role in heart failure pathogenesis.
No takes yet. Share an insight, caveat, or question.
Inexpensive ESR may flag long-term HF risk without changing current practice; leaves open incremental utility versus modern biomarkers in women.
Ingelsson et al. (2005) conducted a cohort in Heart failure (n=2,314). Erythrocyte sedimentation rate (ESR) vs. Lowest quartile of ESR was evaluated on Development of heart failure (HR 1.46, 95% CI 1.04 to 2.06). Elevated erythrocyte sedimentation rate (highest vs. lowest quartile) independently predicted the development of heart failure over 30 years (HR 1.46; 95% CI 1.04-2.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: